Charles Schwab Investment Management Inc Immunity Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,265,981 shares of IBRX stock, worth $3.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,265,981

Previous 1,236,316 2.4%

Holding current value

$3.87 Million

Previous $7.81 Million 39.9%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.32 - $6.7 $98,487 - $198,755	29,665 Added 2.4%	1,265,981 $4.7 Million
Q2 2024 Aug 12, 2024	BUY	$4.82 - $9.15 $313,801 - $595,701	65,104 Added 5.56%	1,236,316 $7.81 Million
Q1 2024 May 08, 2024	BUY	$3.23 - $6.17 $91,367 - $174,530	28,287 Added 2.47%	1,171,212 $6.29 Million
Q4 2023 Feb 06, 2024	BUY	$1.25 - $5.21 $116,238 - $484,483	92,991 Added 8.86%	1,142,925 $5.74 Million
Q3 2023 Nov 08, 2023	BUY	$1.29 - $3.1 $92,089 - $221,299	71,387 Added 7.3%	1,049,934 $1.77 Million
Q2 2023 Aug 09, 2023	BUY	$1.53 - $6.41 $402,255 - $1.69 Million	262,912 Added 36.74%	978,547 $2.72 Million
Q1 2023 May 11, 2023	SELL	$1.35 - $4.78 $10,643 - $37,685	-7,884 Reduced 1.09%	715,635 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $49,159 - $76,507	11,301 Added 1.59%	723,519 $3.67 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $868,510 - $1.53 Million	237,948 Added 50.17%	712,218 $3.54 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $50,354 - $115,364	-18,789 Reduced 3.81%	474,270 $1.77 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.53 $84,193 - $125,540	16,672 Added 3.5%	493,059 $2.77 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $103,091 - $185,092	18,182 Added 3.97%	476,387 $2.9 Million
Q3 2021 Nov 16, 2021	SELL	$9.17 - $14.24 $308,607 - $479,232	-33,654 Reduced 6.84%	458,205 $4.46 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $3.15 Million - $5.26 Million	234,631 Added 91.22%	491,859 $7.02 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $3.3 Million - $10.9 Million	257,228 New	257,228 $6.11 Million

Others Institutions Holding IBRX

# of Institutions

205

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.22B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Immunity Bio, Inc. Transaction History